Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Oncology > Testicular > Flashcards

Testicular Flashcards

1
Q

Most common risk factor for testicular cancer?

A

cryptorchidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is recommended prophylaxis for cryptorchidism?

A

orchiectomy, esp when intra-abdominal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Relative risk of testicular cancer in 1st degree relatives

A

increases 6-10 fold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is intratubular germ cell neoplasia?

A

carcinoma in situ, risk of progression is 50% at 5 years if untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Less common risk factors for testicular cancer?

A 
Hypospadias
HIV (seminomas)
Testicular microlithiasis
Klinefelter & Down syndromes
exposure to exogenous estrogens in utero
peutz-Jegher syndrome and Carney complex (Sertoli cell)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Common presentation for testicular cancer?

A

painless mass, heavy sensation in lower abd or perianal region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the types of testicular tumors?

A

Germ cell (95%)
sex cord tumors
lymphoma, leukemia and plasmacytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are two types of germ cell tumors?

A

Seminoma and nonseminomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the most prevalent and specific cytogenetic abnormality in testicular cancer?

A

gain of 12p sequences; commonly i12p

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are key histologic and serum characteristics of the different germ cell tumor subtypes?

A

Seminoma (pure) - AFP normal; bHCG: normal to mildly elevated; i12p (50%) “min b oma)
Spermatocystic seminoma: i12p (0%)
NSGCTs: i12p (80%)
-Embryonal: AFP & bHCG normal to mildly elevated “um bro could be both”
-Choriocarcinoma: AFP normal, bHCG > 1000 IU/L “human ““chorionic”” gonadotropin “
-Yolk sac: AFP > 100; bHCG normal “fetal yolk”
-Teratoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are key serum tumor markers (STMs) and how are they broken up into mild, mod & high risk? What is their half-life

A

AFP (4-5 days) [ 10,000] “A is a 10 f partner”

b-HCG (18-36 hours) [ 50,000 “beta is two human butt cheegs”

LDH () [10x ULN) “L is 1.5 pieces of wood”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Staging summary for testicular cancer?

A

Stage I: tumor only
Stage II: regional node involvement & mild STMs
Stage III: metastatic or high STMs
- IIIA: nonregional lymph nodes, pulm mets and/or mild STMs
- IIIB: nonregional lymph nodes, pulm mets and/or mod STMs
- IIIC: non pulm mets or marked STMs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are prognostic catergories for Seminoma?

A

No Poor

  • Good: non pulmonary visceral mets; I-IIIB
  • Int: non pulmonary visceral mets: IIIC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are prognositic catergories for NSGCT?

A

Good: I-IIIA
Int: IIIB
Poor: IIIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is likelihood of cure in Stage I seminoma?

A

close to 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is criticial question when determining adjuvant therapy following resection for Stage I seminoma>

A

Is the patient compliant? - relapse rate of 15-20%; down to 5% if given chemo (carbo AUC 7 1-2 cycles or RT (20-25 Gy, PA-strip)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What adjuvant therapy for Stage I Seminoma is preferred but withheld usually?

A

RT, due to secondary malignancies, 18.2% cumulative risk at 25 years; (PA-strip preffered field over hockey-stick and dog-leg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is advantage of single dose of carbo (AUC 7) over RT for Stage I seminoma?

A

Less incidence of new contralateral GCT (0.2% vs 1.2%) 80% risk reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is relapse rate for Stage I Non-seminoma? How many are upstaged to Stage II following RPLND

20
Q

Late recurrences for testicular cancer are common with and uncommon with?

A

common in seminoma and uncommon in non-seminoma

21
Q

What are two important factors in Stage I Non-seminoma that predict for relapse and favor adjuvant intervention?

A

presence of LVI (lymphovascular invasion) * (strongest)

embryonal component predominant

22
Q

What imaging modality is not recommended for NSGCTs

23
Q

What is recommended for adjuvant therapy in high risk Stage I Non-seminoma?

A

RPLND (preferred in US, avoid chemo toxicity, advantage of upstaging) versus chemo (BEP x 1-2, preferred in Europe due to low relapse rate of

24
Q

Key question for Stage I Non-seminoma s/p RPLND?

A

Compliance; if yes surveillance; if no BEP x 2 for pN1 or pN2 disease and BEP x3-4 for pN3 disease

25
Q

Most common complication of nerve sparing RPLND?

A

infertility due to retrograde ejaculation

26
Q

Post-orchiectomy adjuvant therapy for Stage I Non-seminoma with positive STMs?

A

BEP x 3 or EP x 4

27
Q

What does Stage II germ cell tumor imply and how is therapy different from Stage I?

A

Retroperitoneal node involvement; surveillance is not an option

28
Q

What is recommended for adjuvant therapy in Stage II seminoma?

A

IIA: RT (30-35Gy - preffered), or chemo
IIB: Chemo (BEP x 3 - preffered) or RT
IIC: Chemo only (BEP x 3, or EP x 4)

29
Q

Only situation where single agent carboplatin (AUC 7) is an option?

A

Stage I Seminoma

30
Q

What regimen did BEP replace? Advantage

A

PVB; not as good in bulky disease and the vinblastine can result in considerable neuromuscular toxicity

31
Q

BEP 3 versus 4 cycles

A

4 cycles is reserved for Seminoma Int risk and Non-Seminoma Int or Poor risk.; 3 is good for good risk, good?

32
Q

What determines choice between BEP and EP?

A

Pulmonary function (older); or atheletes

33
Q

Rule of thumb for residual masses in testicular germ cell tumors?

A

NSGCTs: always resect
Seminoma: resect based on size criteria of > 3; if well delineated or positive PET after 6 weeks (preferred method)

34
Q

What is recommended for adjuvant therapy in STM negative Stage II Non-seminoma post-orchiectomy?

A
  • similar to seminoma except RPLND replaces RT
    IIA: RPLND or chemo
    IIB: Chemo (BEP x 3 - preffered) or RPLND
    IIC: Chemo only (BEP x 3, or EP x 4)
35
Q

For Stage IIA STM negative Non Seminoma; s/p adjuvant RPLND; if residual disease is present, what determines adjuvant plan?

A

Node status:

  • pN1: surviellance
  • pN2: BEP or EP x2 over surviellance
  • PN3: BEP x 3 or EP x 4
36
Q

For Stage IIC STM negative Non Seminoma; s/p adjuvant chemo; if residual disease is present, what determines adjuvant plan?

A

residual mass > 1 cm: RPLND

if

37
Q

For Stage II STM positive Non Seminoma what is adjuvant recommendation?

A

BEP x3 or EP x 4

38
Q

Why do some providers recommend RPLND after chemotherapy for Stage II or III NSGCTs regardless of response?

A

Growing teratoma syndrome (teratoma’s are relatively resistent to chemotherapy): presents with clinical discordance, dropping STMs and stable or increasing mass

39
Q

For post-chemo NSGCTs patients with positive STMs or residual mass with viable tumor (not fibrosis or teratoma), what is given?

A 
2 cycles of: 
EP, 
VIP (etop/ ifos/ cis), 
VeIP (vinblas/ ifos/ cis), 
TIP (paclitaxel/ ifos/ cis)
40
Q

For Stage III disease what regimen shows similar efficacy to BEP x 4 cycles but increased hematologic and GU toxicity? In what scenario is this regimen preffered?

A

VIP

-lung disease

41
Q

What non-invasive method can help differentiate teratoma from fibrosis?

A

None; only through surgical resection with path analysis

42
Q

What is strongest predictor of fibrosis for residual pulmonary disease in Stage III NSGCTs?

A

necrosis in retroperitoneum on RPLND prior to thoractomy (89% of cases on retrosepctive multicenter study of 215 patients)

43
Q

For GCTs that relapse within 4 weeks of receiving a cisplatin based therapy or during therapy are classified as? What are there options then?
What is 2 years out?

A

platinum refractory or absolutely refractory
- GEMOX based or HDCT
platinum resistant
- paclitaxel or ifosfamide based

44
Q

Extragonadal seminomas have what prognosis and are managed how?

A

Prognosis similar to gonadal primaries and managed similarly.

45
Q

Extragondal germ cell turmor are usually what subtype?

A

non-seminoma; pure seminoma is extremely rare

46
Q

Extragonadal non-seminoma have what prognosis and are managed how?

A

worse than gonadal counterparts; mediastinal are worst, automatically poor prognosis despite marker and disease burden

47
Q

What malignancy is reported with mediastinal non-seminomas?

A

leukemia, esp megakaryocytic lineage

Oncology (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions